• Key Features & Attributes
  • Ratings & Reviews
  • Know your Supplier
  • Product description from supplier

Dapagliflozin Tablets 10 mg

Inclusive of all taxes

Dapagliflozin Tablets 10 mg are precision-formulated oral tablets specifically designed for the effective management of diabetes mellitus. Each tablet contains 10 mg of dapagliflozin, a selective sodium-glucose co-transporter-2 (SGLT2) inhibitor that aids in reducing blood glucose levels by promoting renal glucose excretion. Manufactured by IndiGlobal Exports under stringent WHO-GMP guidelines, these tablets ensure consistent therapeutic performance and high purity standards, making them ideal for international export markets. The product is presented in export-grade blister or strip packaging to maintain drug stability during transport and storage. Carefully developed to meet IP/USP pharmacopoeial standards, Dapagliflozin Tablets 10 mg serve as a reliable treatment option for healthcare professionals managing type 2 diabetes mellitus in various clinical settings. Its formulation and packaging facilitate easy administration and dosage accuracy, supporting improved patient compliance and therapeutic outcomes.

Key Features

Features Description
Active Ingredient Dapagliflozin 10 mg
Indication Management of Type 2 Diabetes Mellitus
Manufacturing Standards WHO-GMP compliant facilities
Packaging Export-grade blister or strip packs
Dosage Form Tablet
Pharmacopoeial Compliance Meets IP/USP quality standards
Therapeutic Function Selective SGLT2 inhibitor reducing blood glucose by renal excretion
Suitable Market International export markets
Manufacturer IndiGlobal Exports
Shelf Life As per regulatory standards
Attributes Description
Category Diabetes
Formulation Tablet
Strength 10 mg per tablet
Packaging Type Blister pack or strip pack (export-grade)
Shelf Life Complies with regulatory guidelines
Manufacturing Compliance WHO-GMP, IP/USP standards
Intended Use Treatment of type 2 diabetes mellitus
Distribution Export and regulated pharmaceutical markets

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.

Be the first to write a review

Dapagliflozin Tablets 10 mg are manufactured in WHO-GMP certified facilities and comply with pharmacopoeial quality standards such as IP and USP to ensure safety, efficacy, and consistent dosage.

Yes, the tablets come in export-grade blister or strip packs designed to protect the product during transit and storage, making them ideal for regulated and semi-regulated international pharmaceutical markets.

The tablets contain dapagliflozin, a selective SGLT2 inhibitor that lowers blood glucose by promoting glucose excretion through the kidneys, effectively managing type 2 diabetes mellitus.

Yes, the Dapagliflozin Tablets 10 mg are available in bulk quantities with packaging optimized for institutional supply and export purposes.

IndiGlobal Exports manufactures these tablets, an established pharmaceutical exporter known for compliance with global quality and regulatory requirements.

  • Incorporation Type

  • GST

  • GST Registration Date

  • Number of Employees

  • Import Export Code (IEC)

  • Year of Establishment

  • Nature of Business

  • GlobalLinker Member Since

Dapagliflozin Tablets 10 mg is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.

Features:
  • Used in the management of diabetes conditions
  • Precise dosage form and active pharmaceutical ingredients
  • Suitable for international pharmaceutical markets
  • Manufactured in GMP-compliant facilities
  • Reliable therapeutic performance
Attributes:
  • Category: Diabetes
  • Formulation: Tablet
  • Packaging: Export-grade blister or strip packs
  • Shelf Life: As per regulatory standards
  • Manufacturer: IndiGlobal Exports
Product Overview

Dapagliflozin Tablets 10 mg is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.


Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.


Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.


Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.



Healthcare

Drugs And Medicine

Cardiovascular Drugs And Medication

Antidiabetic Medicine

Dapagliflozin 10 Mg

Diabetes Tablets Export

SGLT2 Inhibitor Tablets

WHO-GMP Diabetes Medication

IndiGlobal Exports Diabetes Drug

Dapagliflozin Tablets 10 mg

Inclusive of all taxes

You Save: 0

Send Inquiry
IndiGlobal Exports

Panchkula , India

Service Provider , Professional Services, Exporter, Wholesaler

GST- 06EOGPS3248L1ZF

  • Secure
    Transaction

  • Free
    Delivery

  • Day
    Dispatch

Report a problem with this product